Norbert Oppitz
Corporate Officer/Principal bei SWEDISH ORPHAN BIOVITRUM AB
Vermögen: 946 384 $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Norbert Oppitz
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 45 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Norbert Oppitz
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Gambro AB
 Gambro AB Medical SpecialtiesHealth Technology Gambro AB engages in the development and manufacturing of dialysis equipment and blood purification products. It provides products and therapies for kidney and liver dialysis, myeloma kidney therapy, and other extracorporeal therapies for chronic and acute patients. The firm offers products for hemodialysis, acute care, myeloma kidney therapy, and vascular access and water systems. The company was founded by Holger Crafoord in 1964 and is headquartered in Lund, Sweden. | Medical Specialties | Director/Board Member Public Communications Contact Chief Executive Officer Director/Board Member | |
| DOVA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member President | |
| Stockholm School of Economics | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| MEDA AB | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Director/Board Member | |
Takeda Pharmaceuticals International AG
 Takeda Pharmaceuticals International AG Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer President Corporate Officer/Principal | |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Operating Officer | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal General Counsel Director/Board Member | |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Nycomed AB With a broad portfolio of products and a powerful pipeline, they work in a wide range of therapeutic areas, particularly cardiology, gastroenterology, osteoporosis, respiratory, and pain and tissue management. Nycomed engaged in all aspects of a product's life, from research and development to customer relations. They also work closely with innovative research-based companies, constantly looking for products with real promise for patients. They believe that everything do matters to someone. So they work carefully to make sure they get what they do right. They focus on results and respond quickly to the needs of patients and healthcare providers, giving them the best possible experience from working with clients. By doing this, they can achieve vision of being the preferred pharmaceutical company. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal General Counsel | |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum, Inc. operates as an international rare disease company providing access to treatments that make a significant difference for people with rare diseases. Its business areas include haemophilia, immunology and specialty care. The company is headquartered in Waltham, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree Doctorate Degree | |
| BAXALTA INC | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Doctorate Degree | |
| SCANDIC HOTELS GROUP AB | Hotels/Resorts/Cruise lines | Human Resources Officer Human Resources Officer | |
| University of Lund | College/University | Graduate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Investor Relations Contact | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
| Copenhagen Business School | College/University | Undergraduate Degree Masters Business Admin | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
OxThera AB
 OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director of Finance/CFO Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| University of Uppsala | College/University | Undergraduate Degree Graduate Degree | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| INVESTOR AB | Financial Conglomerates | Director of Finance/CFO Corporate Officer/Principal | |
| PHARVARIS N.V. | Pharmaceuticals: Major | Founder Director/Board Member | |
Syncron Holding AB
 Syncron Holding AB Packaged SoftwareTechnology Services Syncron Holding AB provides supply chain management and software solutions. It offers solutions for supply chain planning, business process platform, and global order, supply, and price management. The company's services include professional and inventory planning analyst services, and customer support. Its solutions include global inventory and order management, master data management, business process platform and advanced analytics. Syncron Holding was founded by Hakan Amnas in 1990 and is headquartered in Stockholm, Sweden. | Packaged Software | Director of Finance/CFO | |
Envirotainer AB
 Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Director/Board Member | |
| AMICUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| XBRANE BIOPHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
Pensa Investments SL
 Pensa Investments SL Miscellaneous Commercial ServicesCommercial Services Pensa Investments SL engages in the manufacture of pharmaceutical facilities. The firm specializes in the research, production, development, storage, lease, commercialization, and sale of raw materials and property. The company was founded on December 20, 2019 and is headquartered in Martorelles, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
| BIO-WORKS TECHNOLOGIES AB | Biotechnology | Director/Board Member | |
Pfizer Health AB
 Pfizer Health AB Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Health AB is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Straengnaes, Sweden. The Swedish company was founded in 1969. The CEO is Helena Viktoria Thelin. | Pharmaceuticals: Major | Chief Executive Officer | |
| Coventry University | College/University | Undergraduate Degree | |
| Process Industrial It & Automation | Director/Board Member | ||
| University of Oslo | College/University | Doctorate Degree | |
| Medical University Sofia | College/University | Doctorate Degree | |
Esteve Pharmaceuticals S.A.
 Esteve Pharmaceuticals S.A. Pharmaceuticals: OtherHealth Technology Esteve Pharmaceuticals S.A. operates as a global pharmaceutical company. It provides Ophthalmology and other Pathologies therapies. The company is headquartered in Barcelona, Spain. | Pharmaceuticals: Other | Chief Executive Officer | |
| London Guildhall University | College/University | Undergraduate Degree | |
U-R-Not Ltd.
 U-R-Not Ltd. Miscellaneous Commercial ServicesCommercial Services U-R-Not Ltd. provides other service activities. | Miscellaneous Commercial Services | Director/Board Member | |
Dizlin Medical Design AB
 Dizlin Medical Design AB Pharmaceuticals: MajorHealth Technology Dizlin Medical Design AB manufactures pharmaceutical products. The private company is based in Vimmerby, Sweden. | Pharmaceuticals: Major | Director/Board Member | |
| Lundbeck USA Inc. | President | ||
| van Es Consulting AB | Director/Board Member | ||
| Erasmus University Rotterdam | College/University | Doctorate Degree | |
| ALZECURE PHARMA AB | Biotechnology | Chief Tech/Sci/R&D Officer |
Statistik
International
| Schweden | 29 |
| Vereinigte Staaten | 6 |
| Vereinigtes Königreich | 6 |
| Dänemark | 4 |
| Niederlande | 4 |
Sektoral
| Health Technology | 25 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 4 |
| Technology Services | 2 |
Operativ
| Director/Board Member | 157 |
| Corporate Officer/Principal | 75 |
| Independent Dir/Board Member | 56 |
| Chairman | 43 |
| Chief Tech/Sci/R&D Officer | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Sven Håkan Björklund | 46 |
| Bo Jesper Hansen | 34 |
| Johannes G. C. P. Schikan | 22 |
| Sven Anders Ullman | 19 |
| Guido Oelkers | 19 |
| Henrik Stenqvist | 16 |
| Lena Elisabeth Svanberg | 16 |
| Staffan Schüberg | 15 |
| Matthew David Tooth | 14 |
| Helena Ildiko Saxon | 14 |
| An van Es-Johansson | 13 |
| Hege Hellstrom | 11 |
| Per Richard Torbjörn Hallberg | 10 |
| Annette Clancy | 10 |
| Ravi Rao | 10 |
- Börse
- Insiders
- Norbert Oppitz
- Unternehmensverbindungen
